2m 2m 2m 2m 2m 2m 2m
Organon (OGN)
NYSE
$13.43-$0.02 (-0.16%)
Price as of Jun 23, 2026 7:49 PM EDT- $3.5BMarket Cap
- 37.94%1-Year Change
- Drug Manufacturers - GeneralIndustry
Organon (OGN)
$13.43-$0.02 (-0.16%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 6.2B -2.92% | 6.4B +2.24% | 6.3B +1.44% | 6.2B -2.06% | |
Cost of Revenue | 2.9B +8.00% | 2.7B +6.88% | 2.5B +9.63% | 2.3B -3.69% | |
Gross Profit | 3.3B -10.82% | 3.7B -0.88% | 3.7B -3.40% | 3.9B -1.07% | |
Sales and Marketing Expense | 1.7B -2.22% | 1.8B -7.03% | 1.9B +11.09% | 1.7B +2.16% | |
Research and Development Expense | -366.0M -21.96% | -469.0M -11.17% | -528.0M -8.65% | -578.0M +30.47% | |
Depreciation and Amortization Expense | 156.0M +18.18% | 132.0M +10.00% | 120.0M +25.00% | 96.0M +4.35% | |
Total Operating Expenses | 2.9B +8.00% | 2.7B +6.88% | 2.5B +9.63% | 2.3B -3.69% | |
Operating Profit | 425.0M -47.34% | 807.0M +19.91% | 673.0M -40.02% | 1.1B -26.62% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -504.0M -3.08% | -520.0M -1.33% | -527.0M +24.88% | -422.0M +63.57% | |
Interest Income and Expense and Net | -504.0M -3.08% | -520.0M -1.33% | -527.0M +24.88% | -422.0M +63.57% | |
Total Nonoperating Income and Expense | 504.0M -3.08% | 520.0M -1.33% | 527.0M +24.88% | 422.0M +63.57% | |
Income before Taxes | 425.0M -47.34% | 807.0M +19.91% | 673.0M -40.02% | 1.1B -26.62% | |
Income Taxes | 238.0M +517.54% | -57.0M -83.71% | -350.0M -270.73% | 205.0M +15.17% | |
Extraordinary Items | N/A N/A | 9.0M N/A | 0 -100.00% | 9.0M +28.57% | |
Net Income | 187.0M -78.36% | 864.0M -15.54% | 1.0B +11.56% | 917.0M -32.12% | |
Net Income from Continuing Operations Applicable to Common | 425.0M -47.34% | 807.0M -21.11% | 1.0B +11.56% | 917.0M -32.12% | |
Basic EPS and Net Income | 0.72 -78.57% | 3.36 -16.21% | 4.01 +11.08% | 3.61 -32.27% | |
Diluted EPS and Net Income | 0.72 -78.38% | 3.33 -16.54% | 3.99 +11.14% | 3.59 -32.39% | |
Basic Weighted Average Shares | 259.5M +0.95% | 257.0M +0.71% | 255.2M +0.46% | 254.1M +0.21% | |
Diluted Weighted Average Shares | 260.8M +0.62% | 259.2M +1.12% | 256.3M +0.43% | 255.2M +0.38% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 574.0M -14.96% | 675.0M -2.60% | 693.0M -1.84% | 706.0M -4.21% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 574.0M -14.96% | 675.0M -2.60% | 693.0M -1.84% | 706.0M -4.21% | |
Total Current Assets | 4.4B +0.09% | 4.3B -3.55% | 4.5B +14.68% | 3.9B +4.55% | |
Accumulated Depreciation | 1.2B +16.89% | 1.1B +4.23% | 1.0B +12.75% | 902.0M +2.27% | |
Property and Plant and Equipment and Net | 1.3B +11.56% | 1.2B -1.27% | 1.2B +16.21% | 1.0B +4.62% | |
Total Long-Term Assets | 1.3B +11.56% | 1.2B -1.27% | 1.2B +16.21% | 1.0B +4.62% | |
Total Assets | 12.9B -1.79% | 13.1B +8.65% | 12.1B +10.07% | 11.0B +2.57% | |
Income Taxes Payable | 142.0M -31.73% | 208.0M -17.79% | 253.0M +24.63% | 203.0M +7.41% | |
Total Short-Term Debt | 16.0M -20.00% | 20.0M +122.22% | 9.0M +12.50% | 8.0M -11.11% | |
Total Current Liabilities | 2.4B -12.07% | 2.7B -6.85% | 2.9B +16.16% | 2.5B -3.27% | |
Total Long-Term Debt | 8.6B -2.62% | 8.9B +1.25% | 8.8B -1.73% | 8.9B -2.41% | |
Total Long-Term Liabilities | 1.0B +3.17% | 977.0M +137.14% | 412.0M +0.24% | 411.0M -11.23% | |
Total Liabilities | 12.1B -4.07% | 12.6B +4.13% | 12.1B +382.80% | 2.5B -3.27% | |
Retained Earnings | 1.1B +9.80% | 1.0B +127.99% | 443.0M +233.84% | -331.0M -66.83% | |
Total Stockholders Equity | 752.0M +59.32% | 472.0M +774.29% | -70.0M -92.15% | -892.0M -40.85% | |
Total Shares Outstanding | 260.3M +0.98% | 257.8M +0.85% | 255.6M +0.49% | 254.4M +0.32% | |
Cash Flow | |||||
Cash from Operating Activities | 700.0M -25.45% | 939.0M +17.52% | 799.0M -6.88% | 858.0M -65.09% | |
Capital Expenditures | 162.0M -7.43% | 175.0M -30.28% | 251.0M +28.06% | 196.0M +2.08% | |
Cash from Investing Activities | -390.0M -23.98% | -513.0M +97.31% | -260.0M -38.10% | -420.0M -12.68% | |
Dividends Paid | 88.0M -70.37% | 297.0M +1.02% | 294.0M +1.38% | 290.0M +100.00% | |
Cash from Financing Activities | -561.0M +52.45% | -368.0M -35.33% | -569.0M +31.41% | -433.0M -67.52% | |
Financials Ratio | |||||
Gross Margin | 53.30% -8.14% | 58.02% -3.05% | 59.84% -4.77% | 62.84% N/A | |
Operating Margin | 6.84% -45.75% | 12.60% +17.29% | 10.75% -40.87% | 18.17% N/A | |
Return on Assets | 1.44% -79.03% | 6.87% -22.75% | 8.89% +4.88% | 8.48% N/A | |
Return on Equity | 30.56% -92.89% | 429.85% +302.11% | -212.68% +178.32% | -76.42% N/A | |
Revenue Growth | -2.92% -230.65% | 2.24% +55.07% | 1.44% +169.90% | -2.06% N/A | |
Current Ratio | 1.82 +13.83% | 1.60 +3.55% | 1.54 -1.28% | 1.56 N/A | |
Cash Ratio | 0.24 -3.26% | 0.25 +4.55% | 0.24 -15.51% | 0.28 N/A | |
Debt-to-Equity Ratio | 11.49 -38.90% | 18.81 +115.03% | -125.14 +1,152.41% | -9.99 N/A | |
Debt-to-Assets Ratio | 0.67 -0.89% | 0.68 -6.70% | 0.73 -10.71% | 0.81 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow